SUBSCRIBE
SUBSCRIBE

Medexus Pharma

NEWS
FDA
FDA Action Alert: Medexus and Jazz
Although August is a fairly busy month for PDUFA dates, there were only two on the U.S. FDA’s calendar for this week, and one of those has already been reported. Here’s a look.
August 6, 2021
 · 
3 min read
 · 
Mark Terry
Business
Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2020 Conference Call
Medexus Pharmaceuticals Inc. announced that it plans to host a conference call at 8:00 AM Eastern Time on Monday, December 2, 2019 to discuss the Company’s financial results for the second quarter ended September 30, 2019, as well as the Company’s corporate progress and other developments.
November 27, 2019
 · 
2 min read
JOBS
IN THE PRESS
Press Releases
Medexus Announces Strong Fiscal Q2 2025 Results
November 7, 2024
 · 
23 min read
Press Releases
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
September 20, 2024
 · 
3 min read
Press Releases
Medexus Provides Update on Treosulfan NDA Review Process and Extended PDUFA Goal Date
September 16, 2024
 · 
4 min read
Press Releases
Medexus Announces Strong Fiscal Q1 2025 Results
August 8, 2024
 · 
20 min read
Press Releases
Medexus Schedules First Fiscal Quarter 2025 Conference Call
July 30, 2024
 · 
3 min read
Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024
June 25, 2024
 · 
23 min read
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call
June 18, 2024
 · 
3 min read
Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada
May 2, 2024
 · 
4 min read
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 2, 2024
 · 
3 min read
FDA
FDA Approves Medexus’s Supplemental Biologics License Application for IXINITY(R) to Treat Hemophilia B in Pediatric Patients
March 26, 2024
 · 
7 min read
Load More